358 related articles for article (PubMed ID: 24487006)
1. Elevated day 3 follicle-stimulating hormone in younger women: is gonadotropin stimulation/intrauterine insemination a good option?
Souter I; Dimitriadis I; Baltagi LM; Meeker JD; Petrozza JC
Am J Obstet Gynecol; 2014 Jul; 211(1):62.e1-8. PubMed ID: 24487006
[TBL] [Abstract][Full Text] [Related]
2. Do younger women with elevated basal follicular stimulating hormone levels undergoing gonadotropin-stimulated intrauterine insemination cycles represent compromised reproductive outcomes?
Devranoğlu B; Özdamar Ö; Köle E; Eken MK; Bozdağ H; Doğer E
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():141-5. PubMed ID: 26930042
[TBL] [Abstract][Full Text] [Related]
3. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
Noriega-Portella L; Noriega-Hoces L; Delgado A; Rubio J; Gonzales-Castañeda C; Gonzales GF
Fertil Steril; 2008 Nov; 90(5):1818-25. PubMed ID: 18083169
[TBL] [Abstract][Full Text] [Related]
4. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
[TBL] [Abstract][Full Text] [Related]
5. Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles.
Gómez-Palomares JL; Acevedo-Martín B; Chávez M; Manzanares M; Ricciarelli E; Hernández ER
Fertil Steril; 2008 Mar; 89(3):620-4. PubMed ID: 17678911
[TBL] [Abstract][Full Text] [Related]
6. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination.
Kabli N; Sylvestre C; Tulandi T; Buckett W
Fertil Steril; 2009 Apr; 91(4):1141-4. PubMed ID: 18342857
[TBL] [Abstract][Full Text] [Related]
7. The importance of infertility duration and follicle size according to pregnancy success in women undergoing ovulation induction with gonadotropins and intrauterine insemination.
Kuru Pekcan M; Tokmak A; Ulubasoglu H; Kement M; Özakşit G
J Obstet Gynaecol; 2023 Dec; 43(1):2173058. PubMed ID: 36920100
[TBL] [Abstract][Full Text] [Related]
8. Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.
Rashidi M; Aaleyasin A; Aghahosseini M; Loloi S; Kokab A; Najmi Z
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):244-7. PubMed ID: 23541417
[TBL] [Abstract][Full Text] [Related]
9. Management of ovulation induction and intrauterine insemination in infertile patients with hypogonadotropic hypogonadism.
Huseyin K; Berk B; Tolga K; Eser O; Ali G; Murat A
J Gynecol Obstet Hum Reprod; 2019 Dec; 48(10):833-838. PubMed ID: 30930300
[TBL] [Abstract][Full Text] [Related]
10. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
[TBL] [Abstract][Full Text] [Related]
11. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
Barad DH; Weghofer A; Gleicher N
Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
[TBL] [Abstract][Full Text] [Related]
12. A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertility.
Wu HH; Wang NM; Cheng ML; Hsieh JN
Gynecol Endocrinol; 2007 Feb; 23(2):76-81. PubMed ID: 17454156
[TBL] [Abstract][Full Text] [Related]
13. Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study.
Kocak M; Dilbaz B; Demir B; Taşci Y; Tarcan A; Dede S; Haberal A
Gynecol Endocrinol; 2010 Jun; 26(6):429-34. PubMed ID: 20175705
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for pregnancy after intrauterine insemination (IUI): an analysis of 1038 cycles and a review of the literature.
Merviel P; Heraud MH; Grenier N; Lourdel E; Sanguinet P; Copin H
Fertil Steril; 2010 Jan; 93(1):79-88. PubMed ID: 18996517
[TBL] [Abstract][Full Text] [Related]
15. Recombinant FSH increases live birth rates as compared to clomiphene citrate in intrauterine insemination cycles in couples with subfertility: a prospective randomized study.
Erdem M; Abay S; Erdem A; Firat Mutlu M; Nas E; Mutlu I; Oktem M
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():33-7. PubMed ID: 25855325
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
17. Follicular phase dynamics with combined aromatase inhibitor and follicle stimulating hormone treatment.
Bedaiwy MA; Mousa NA; Esfandiari N; Forman R; Casper RF
J Clin Endocrinol Metab; 2007 Mar; 92(3):825-33. PubMed ID: 17192292
[TBL] [Abstract][Full Text] [Related]
18. Falling FSH levels predict poor IVF pregnancy rates in patients whom the gonadotropins are withheld.
Erman Akar M; Oktay K
Arch Gynecol Obstet; 2009 Nov; 280(5):761-5. PubMed ID: 19255769
[TBL] [Abstract][Full Text] [Related]
19. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
[TBL] [Abstract][Full Text] [Related]
20. Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination.
Mitwally MF; Abdel-Razeq S; Casper RF
Reprod Biol Endocrinol; 2004 Jul; 2():55. PubMed ID: 15239837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
